Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessment.
Vaccine
; 39(22): 3081-3101, 2021 05 21.
Article
in En
| MEDLINE
| ID: mdl-33676782
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Viral Vaccines
/
Ebolavirus
/
COVID-19
Type of study:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Vaccine
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: